Starsource Multitrade closes trading window from Oct 1 for Q2FY27 results

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Trading window closes from October 1, 2026
  • Restriction applies until two days post-Q2FY27 results
  • Covers promoters, directors, and KMPs under insider trading code
powered bylight_fuzz_icon
51977618

*this image is generated using AI for illustrative purposes only.

Starsource Multitrade Limited will close its trading window for all designated persons starting October 1, 2026. The closure remains in effect until two clear trading days after the announcement of un-audited financial results for the quarter ending September 30, 2026.

This action is taken pursuant to the company's Code of Conduct for Prevention of Insider Trading. The restriction applies to promoters, directors, key managerial personnel, designated employees, and other connected persons. These individuals have been intimated not to trade in the securities of the company during this period.

Regulatory Compliance and Timeline

The trading window closure is a standard compliance measure to prevent insider trading ahead of significant financial disclosures. The company stated that the date of the board meeting to consider and approve the said results will be intimated in due course.

Event Date / Status
Trading Window Closure Start October 1, 2026
Reporting Period Quarter ending September 30, 2026
Window Reopening Two clear trading days after result announcement
Board Meeting Date To be intimated in due course

Scope of Restriction

The prohibition on trading extends to all securities of the company. By enforcing this blackout period, Starsource Multitrade ensures that no privileged information regarding the upcoming quarterly performance influences market transactions. The specific date for the board meeting to approve the financial results has not yet been announced.

Historical Stock Returns for Star Source Multi Trade

1 Day5 Days1 Month6 Months1 Year5 Years
-3.77%-0.60%-17.73%-24.06%-37.47%+197.96%

How might the upcoming Q2 FY27 financial results influence investor sentiment and stock volatility for Starsource Multitrade Limited?

Are there any anticipated changes in the company's capital allocation strategy or dividend policy expected from the board meeting approving these results?

What impact could the trading window closure have on short-term liquidity and trading volumes for the company's securities during the blackout period?

Star Source Multi Trade
View Company Insights
View All News
like15
dislike

Starsource Multitrade schedules 84th AGM for September 28

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Book closure set from September 22 to 27, 2026
  • 84th AGM scheduled for September 28 via video conference
  • MD Ruchit Mehta seeks re-appointment by rotation
  • Remote e-voting opens on September 25 through CDSL
powered bylight_fuzz_icon
49363127

*this image is generated using AI for illustrative purposes only.

Starsource Multitrade Limited has announced that its register of members and share transfer books will remain closed from Tuesday, September 22, 2026, to Saturday, September 27, 2026. This closure is for the purpose of its 84th Annual General Meeting, scheduled for Monday, September 28, 2026.

The company, formerly known as Chemo Pharma Laboratories Limited, confirmed that the record date for e-voting is set for Monday, September 21, 2026. Shareholders holding equity shares of face value ₹10 each on this record date will be eligible to vote at the AGM.

Meeting Details

The 84th AGM will be conducted through Video Conferencing or Other Audio-Visual Means (VC/OAVM) in compliance with SEBI and MCA regulations. The meeting is scheduled for 4:00 pm on September 28, 2026.

The Board of Directors approved these details during a meeting held on Tuesday, September 1, 2026, at the company’s registered office in Kalyan. The board also appointed a scrutinizer for the meeting and fixed the book closure dates.

Agenda and Re-appointment

The primary agenda for the meeting includes considering and adopting the Audited Financial Statements for the Financial Year ended March 31, 2026, along with the reports of the Board of Directors and Auditors.

Additionally, shareholders will vote on the re-appointment of Mr. Ruchit Mehta (DIN: 08810586), the Managing Director & Chief Executive Officer, who retires by rotation and is offering himself for re-appointment.

Voting Process

Pursuant to Section 108 of the Companies Act, 2013, the company has engaged Central Depository Services (India) Limited (CDSL) to facilitate remote e-voting. The remote e-voting period commences on Thursday, September 25, 2026, at 9:00 am and ends on Saturday, September 27, 2026, at 5:00 pm.

Members can join the AGM in VC/OAVM mode 15 minutes before the scheduled time. The facility is available to at least 1,000 members on a first-come, first-served basis, excluding large shareholders (holding 2% or more), promoters, institutional investors, and directors. Physical attendance and proxy appointments are not permitted for this virtual meeting.

Compliance and Filings

Starsource Multitrade filed the intimation regarding the book closure with the Bombay Stock Exchange on September 1, 2026. This filing was made pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 91 of the Companies Act, 2013.

Previously, the company published newspaper advertisements in Business Standard and Mumbai Lakshdeep on August 31, 2026, to inform equity shareholders about the virtual meeting format. The initial intimation for the AGM was filed with BSE on August 27, 2026.

Historical Stock Returns for Star Source Multi Trade

1 Day5 Days1 Month6 Months1 Year5 Years
-3.77%-0.60%-17.73%-24.06%-37.47%+197.96%

How might the re-appointment of CEO Ruchit Mehta influence the company's strategic direction and operational efficiency in the upcoming fiscal year?

What specific financial metrics or performance indicators should investors scrutinize in the audited statements for FY ended March 31, 2026, to assess the company's health?

Could the transition from Chemo Pharma Laboratories to Starsource Multitrade signal a broader business model shift, and how will this impact future revenue streams?

Star Source Multi Trade
View Company Insights
View All News
like19
dislike

More News on Star Source Multi Trade

1 Year Returns:-37.47%